Tokyo, Nov. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059759) titled 'Descriptive statistics of WHO-HPQ and SPQ in the Japanese workplace' on Nov. 14.
Study Type:
Observational
Primary Sponsor:
Institute - ADVANTAGE Risk Management Co., Ltd.
Condition:
Condition - none
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Descriptive statistics of WHO-HPQ and SPQ in the Japanese workplace
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - none
Key exclusion criteria - none
Target Size - 900000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2024 Year 03 Month 27 Day
Date of IRB - 2024 Year 04 Month 09 Day
Anticipated trial start date - 2024 Year 04 Month 09 Day
Last follow-up date - 2024 Year 04 Month 09 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060372
Disclaimer: Curated by HT Syndication.
